IGC Pharma (IGC) Price to Earnings (2010 - 2025)
IGC Pharma's (IGC) quarterly Price to Earnings came in at 21.05 in Q3 2025, down 10.49% year-over-year from 23.52 in Q3 2024, and down 128.71% quarter-over-quarter from 9.21 in Q2 2025.
Powered by 
Analysis
IGC Pharma (IGC) Price to Earnings (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Price to Earnings for 16 consecutive years, with 21.05 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Price to Earnings fell 10.49% year-over-year to 21.05 in Q3 2025; TTM through Sep 2025 was 5.01, a 50.81% decrease from a year earlier, with the FY2026 full-year figure at 10.82, down 126.01% from the prior year.
- Price to Earnings was 21.05 for Q3 2025 at IGC Pharma, down from 9.21 in the prior quarter.
- Over five years, Price to Earnings peaked at 3.19 in Q4 2023 and troughed at 172.11 in Q1 2024.
- A 5-year average of 26.43 and a median of 14.37 in 2024 frame the typical range for Price to Earnings.
- Across the five-year window, Price to Earnings tumbled 1441.53% in 2024 and soared 88.82% in 2025, its largest moves.
- Over 5 years, Price to Earnings stood at 20.94 in 2021, then surged by 64.15% to 7.51 in 2022, then jumped by 57.45% to 3.19 in 2023, then sank by 349.78% to 14.37 in 2024, then sank by 46.54% to 21.05 in 2025.
- The last three Price to Earnings figures came in at 21.05 (Q3 2025), 9.21 (Q2 2025), and 19.24 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | IGC Pharma | 27.77 Mn | 27.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -21.05 |
| Jun 30, 2025 | -9.21 |
| Mar 31, 2025 | -19.24 |
| Dec 31, 2024 | -14.37 |
| Sep 30, 2024 | -19.05 |
| Jun 30, 2024 | -13.80 |
| Mar 31, 2024 | -172.11 |
| Dec 31, 2023 | -3.19 |
| Sep 30, 2023 | -9.34 |
| Jun 30, 2023 | -7.97 |
| Mar 31, 2023 | -11.16 |
| Dec 31, 2022 | -7.51 |
| Sep 30, 2022 | -9.37 |
| Jun 30, 2022 | -9.87 |
| Mar 31, 2022 | -14.46 |
| Dec 31, 2021 | -20.94 |
| Sep 30, 2021 | -17.39 |
| Jun 30, 2021 | -44.29 |
| Mar 31, 2021 | -77.90 |
| Dec 31, 2020 | -27.74 |